Onsite Diagnostic Labs India Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
- Paid Up Capital ₹ 2.00 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 333.67%
- Ebitda 799.03%
- Net Worth 30.76%
- Total Assets 311.44%
About Onsite Diagnostic Labs India
Onsite Diagnostic Labs India Private Limited (ODLIPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 May 2015 (Nine years and eight months 24 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Raman Singh and Jagdeep Singh serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33119MP2015PTC034207
-
Company No.
034207
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Onsite Diagnostic Labs India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raman Singh
|
Director | 18-May-2015 | Current |
|
Jagdeep Singh
|
Director | 18-May-2015 | Current |
Financial Performance of Onsite Diagnostic Labs India.
Onsite Diagnostic Labs India Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 333.67% increase in profit. The company's net worth Soared by an impressive increase of 30.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onsite Diagnostic Labs India?
In 2020, Onsite Diagnostic Labs India had a promoter holding of 26.95% and a public holding of 73.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Gastrolab India Private LimitedJagdeep Singh is a mutual person
-
International Schools Sports OrganisationJagdeep Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Onsite Diagnostic Labs India?
Unlock and access historical data on people associated with Onsite Diagnostic Labs India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onsite Diagnostic Labs India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onsite Diagnostic Labs India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.